(Q38333672)

2 September 2017

Association of mannose-binding lectin-2 gene polymorphism with the development of hepatitis C-induced hepatocellular carcinoma (English)

1 reference

2 September 2017

8

Peter Neuhaus

1 reference

2 September 2017

9

Marcus Bahra

1 reference

2 September 2017

Dennis Eurich

1

1 reference

2 September 2017

Sabine Boas-Knoop

2

1 reference

2 September 2017

Lars Morawietz

3

1 reference

2 September 2017

Ruth Neuhaus

4

1 reference

2 September 2017

Rajan Somasundaram

5

1 reference

2 September 2017

Martin Ruehl

6

1 reference

2 September 2017

Ulf P Neumann

7

1 reference

2 September 2017

Daniel Seehofer

10

1 reference

2 September 2017

15 April 2011

1 reference

2 September 2017

1 reference

2 September 2017

31

1 reference

2 September 2017

7

1 reference

2 September 2017

1006-1012

1 reference

[Chronic HCV infections. A model disease for therapy, economics and social-medical aspects]

2 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02522.X

Molecular viral oncology of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02522.X

Hepatitis C and liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02522.X

Host genetic factors influence disease progression in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02522.X

MBL2 and MASP2 gene polymorphisms in patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02522.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02522.X

CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02522.X

Disease-associated mutations in human mannose-binding lectin compromise oligomerization and activity of the final protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02522.X

Mannose binding lectin (MBL) genotype distributions with relation to serum levels in UK Caucasoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02522.X

Mannose-binding lectin polymorphisms in patients with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02522.X

Hepatitis C virus infection and mutations of mannose-binding lectin gene MBL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02522.X

Mannose-binding lectin deficiency offers protection from acute graft rejection after heart transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02522.X

Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02522.X

Mannose-binding lectin concentrations, MBL2 polymorphisms, and susceptibility to respiratory tract infections in young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02522.X

Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02522.X

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02522.X

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02522.X

Association of hepatitis C virus infection and liver fibrosis severity with the variants alleles of MBL2 gene in a Brazilian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02522.X

Mannan-binding lectin and hepatitis C infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02522.X

Mannan binding lectin and viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02522.X

Treatment of patients with recurrent hepatitis C after liver transplantation with peginterferon alfa-2B plus ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02522.X

Transforming growth factor β1 polymorphisms and progression of graft fibrosis after liver transplantation for hepatitis C virus--induced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02522.X

Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02522.X

Mannose-binding lectin-2 genetic variation and stomach cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02522.X

Donor Mannose‐Binding Lectin Deficiency Increases the Likelihood of Clinically Significant Infection after Liver Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2011.02522.X

10.1111/J.1478-3231.2011.02522.X

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference